BE659663A - - Google Patents

Info

Publication number
BE659663A
BE659663A BE659663DA BE659663A BE 659663 A BE659663 A BE 659663A BE 659663D A BE659663D A BE 659663DA BE 659663 A BE659663 A BE 659663A
Authority
BE
Belgium
Application number
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of BE659663A publication Critical patent/BE659663A/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D321/00Heterocyclic compounds containing rings having two oxygen atoms as the only ring hetero atoms, not provided for by groups C07D317/00 - C07D319/00
    • C07D321/02Seven-membered rings
    • C07D321/10Seven-membered rings condensed with carbocyclic rings or ring systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
BE659663D 1964-02-14 1965-02-12 BE659663A (en:Method)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB6225/64A GB1023796A (en) 1964-02-14 1964-02-14 Guanidino compounds

Publications (1)

Publication Number Publication Date
BE659663A true BE659663A (en:Method) 1965-08-12

Family

ID=9810688

Family Applications (1)

Application Number Title Priority Date Filing Date
BE659663D BE659663A (en:Method) 1964-02-14 1965-02-12

Country Status (7)

Country Link
US (1) US3306913A (en:Method)
BE (1) BE659663A (en:Method)
BR (1) BR6567082D0 (en:Method)
CH (1) CH451194A (en:Method)
FR (1) FR4600M (en:Method)
GB (1) GB1023796A (en:Method)
SE (1) SE324160B (en:Method)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3882147A (en) * 1969-06-09 1975-05-06 Merck & Co Inc 3-Hydroxy-3-(3,4-methylenedioxyphenylalkyl-3,4-dihydro-2H-1,5-benzodioxepin products
US3700691A (en) * 1969-06-09 1972-10-24 Frosst & Co Charles E 3,3-disubstituted-3,4-dihydrobenzodioxepins
US3907793A (en) * 1972-05-01 1975-09-23 Merck & Co Inc 3-Hydroxy-3-morpholino-loweralkyl-3,4-dihydro-2H-1,5-benzodioxepin products
US4234598A (en) * 1979-04-11 1980-11-18 Hoffmann-La Roche Inc. Phenylcarbamates
US4423063A (en) * 1980-12-29 1983-12-27 Merck & Co., Inc. 2,4-Dioxo-4-substituted-1-butaoic acid derivatives useful in treating urinary track calcium oxalate lithiasis
DK166779B1 (da) * 1983-12-14 1993-07-12 Takeda Chemical Industries Ltd 1,5-benzoxatiepinderivater eller farmaceutisk acceptable salte deraf, samt farmaceutisk praeparat indeholdende en saadan forbindelse
US4736031A (en) * 1985-06-10 1988-04-05 Takeda Chemical Industries, Ltd. 2-(piperazinylalkyl)-1-benzothiepin, 1-benzoxepin, and 1,5-benzodioxepin derivatives

Also Published As

Publication number Publication date
SE324160B (en:Method) 1970-05-25
BR6567082D0 (pt) 1973-08-14
GB1023796A (en) 1966-03-23
US3306913A (en) 1967-02-28
FR4600M (en:Method) 1966-11-21
CH451194A (de) 1968-05-15

Similar Documents

Publication Publication Date Title
BE659422A (en:Method)
BE642652A (en:Method)
BE432268A (en:Method)
BE47396A (en:Method)
BE483969A (en:Method)
BE507097A (en:Method)
BE518974A (en:Method)
BE554195A (en:Method)
BE564626A (en:Method)
BE584699A (en:Method)
BE603534A (en:Method)
BE610935A (en:Method)
BE613833A (en:Method)
BE621510A (en:Method)
BE622126A (en:Method)
BE623398A (en:Method)
BE626083A (en:Method)
BE626684A (en:Method)
BE627057A (en:Method)
BE627390A (en:Method)
BE627931A (en:Method)
BE628611A (en:Method)
BE629793A (en:Method)
BE632875A (en:Method)
BE636791A (en:Method)